BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31779999)

  • 21. Triangulating web & general population surveys: Do results match legal cannabis market sales?
    Caulkins JP; Davenport S; Doanvo A; Furlong K; Siddique A; Turner M; Kilmer B
    Int J Drug Policy; 2019 Nov; 73():293-300. PubMed ID: 31272752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of cannabis legalization on healthcare utilization for psychosis and schizophrenia in Colorado.
    Wang GS; Buttorff C; Wilks A; Schwam D; Tung G; Pacula RL
    Int J Drug Policy; 2022 Jun; 104():103685. PubMed ID: 35429874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Legal cannabis market shares during Canada's first year of recreational legalisation.
    Armstrong MJ
    Int J Drug Policy; 2021 Feb; 88():103028. PubMed ID: 33221614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Over-the-counter sleep aids: widely used but rarely studied.
    Pillitteri JL; Kozlowski LT; Person DC; Spear ME
    J Subst Abuse; 1994; 6(3):315-23. PubMed ID: 7703708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In the weeds: a baseline view of cannabis use among legalizing states and their neighbours.
    Pacula RL; Jacobson M; Maksabedian EJ
    Addiction; 2016 Jun; 111(6):973-80. PubMed ID: 26687431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recreational Cannabis Legalization and Opioid-Related Deaths in Colorado, 2000-2015.
    Livingston MD; Barnett TE; Delcher C; Wagenaar AC
    Am J Public Health; 2017 Nov; 107(11):1827-1829. PubMed ID: 29019782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Over-the-Counter Medicines Market in Poland.
    Lasota D; Mirowska-Guzel D; Goniewicz M
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cigarillo sales in legalized marijuana markets in the U.S.
    Giovenco DP; Spillane TE; Mauro CM; Martins SS
    Drug Alcohol Depend; 2018 Apr; 185():347-350. PubMed ID: 29500953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and Predictors of Prescription Sleep Aid Use among Individuals with DSM-5 Insomnia: The Role of Hyperarousal.
    Pillai V; Cheng P; Kalmbach DA; Roehrs T; Roth T; Drake CL
    Sleep; 2016 Apr; 39(4):825-32. PubMed ID: 26943472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Big data on a big new market: Insights from Washington State's legal cannabis market.
    Caulkins JP; Bao Y; Davenport S; Fahli I; Guo Y; Kinnard K; Najewicz M; Renaud L; Kilmer B
    Int J Drug Policy; 2018 Jul; 57():86-94. PubMed ID: 29709847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Over-the-counter sleeping pills: a survey of use in Hong Kong and a review of their constituents.
    Chung KF; Lee CK
    Gen Hosp Psychiatry; 2002; 24(6):430-5. PubMed ID: 12490346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Impacts of Marijuana Legalization: An Evaluation of Prices in Colorado and Washington.
    Hunt P; Pacula RL
    J Prim Prev; 2017 Jun; 38(3):221-248. PubMed ID: 28456861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The supply-side effects of cannabis legalization.
    Han J; Ng'ombe JN
    J Cannabis Res; 2022 Jul; 4(1):40. PubMed ID: 35864509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users.
    Belendiuk KA; Babson KA; Vandrey R; Bonn-Miller MO
    Addict Behav; 2015 Nov; 50():178-81. PubMed ID: 26151582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attitudes towards sales and use of over-the-counter drugs in Sweden in a reregulated pharmacy market: a population-based study.
    Hedenrud T; Andersson Sundell K; Martinsson J; Håkonsen H
    Int J Pharm Pract; 2019 Feb; 27(1):17-24. PubMed ID: 29687513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Next-day residual sedative effect after nighttime administration of an over-the-counter antihistamine sleep aid, diphenhydramine, measured by positron emission tomography.
    Zhang D; Tashiro M; Shibuya K; Okamura N; Funaki Y; Yoshikawa T; Kato M; Yanai K
    J Clin Psychopharmacol; 2010 Dec; 30(6):694-701. PubMed ID: 21105284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Greater Extent of Insomnia Symptoms and Physician-Recommended Sleep Medication Use Predict Fall Risk in Community-Dwelling Older Adults.
    Chen TY; Lee S; Buxton OM
    Sleep; 2017 Nov; 40(11):. PubMed ID: 29029240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Over and under-regulation in the Colorado Cannabis industry - A data-analytic perspective.
    Yates D; Speer J
    Int J Drug Policy; 2018 Sep; 59():63-66. PubMed ID: 30015248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent trends in cyclic vomiting syndrome-associated hospitalisations with liberalisation of cannabis use in the state of Colorado.
    Bhandari S; Jha P; Lisdahl KM; Hillard CJ; Venkatesan T
    Intern Med J; 2019 May; 49(5):649-655. PubMed ID: 30426628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial.
    Morin CM; Koetter U; Bastien C; Ware JC; Wooten V
    Sleep; 2005 Nov; 28(11):1465-71. PubMed ID: 16335333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.